XORTX Therapeutics Inc. (XRTX.V)

CAD 1.38

(-5.48%)

Gross Profit Summary of XORTX Therapeutics Inc.

  • XORTX Therapeutics Inc.'s latest annual gross profit in 2023 was -188.54 Thousand CAD , down -150.5% from previous year.
  • XORTX Therapeutics Inc.'s latest quarterly gross profit in 2024 Q2 was - USD , up 100.0% from previous quarter.
  • XORTX Therapeutics Inc. reported a annual gross profit of -75.26 Thousand CAD in annual gross profit 2022, down -320.91% from previous year.
  • XORTX Therapeutics Inc. reported a annual gross profit of -17.88 Thousand CAD in annual gross profit 2021, up 12.51% from previous year.
  • XORTX Therapeutics Inc. reported a quarterly gross profit of - USD for 2024 Q2, up 100.0% from previous quarter.
  • XORTX Therapeutics Inc. reported a quarterly gross profit of -43 Thousand USD for 2023 Q2, up 52.44% from previous quarter.

Annual Gross Profit Chart of XORTX Therapeutics Inc. (2023 - 2014)

Historical Annual Gross Profit of XORTX Therapeutics Inc. (2023 - 2014)

Year Gross Profit Gross Profit Growth
2023 -188.54 Thousand CAD -150.5%
2022 -75.26 Thousand CAD -320.91%
2021 -17.88 Thousand CAD 12.51%
2020 -20.43 Thousand CAD -2.71%
2019 -19.9 Thousand CAD -3.02%
2018 -19.31 Thousand CAD 0.0%
2017 - CAD 0.0%
2016 - CAD 0.0%
2014 - CAD 0.0%

Peer Gross Profit Comparison of XORTX Therapeutics Inc.

Name Gross Profit Gross Profit Difference
Arch Biopartners Inc. -128.99 Thousand CAD -46.166%
Covalon Technologies Ltd. 14.36 Million CAD 101.313%
Hemostemix Inc. -223.00 CAD -84448.43%
Universal Ibogaine Inc. 1.07 Million CAD 117.608%
Kane Biotech Inc. 109.47 Thousand CAD 272.233%
MedMira Inc. -434.91 Thousand CAD 56.648%
Marvel Biosciences Corp. -887.51 Thousand CAD 78.756%
NervGen Pharma Corp. -145 Thousand CAD -30.027%